{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T16:28:47Z","timestamp":1789921727227,"version":"4.0.1"},"reference-count":68,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Pharmacology"],"published-print":{"date-parts":[[2020,3,3]]},"DOI":"10.1080\/17512433.2020.1743175","type":"journal-article","created":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T20:11:29Z","timestamp":1584130289000},"page":"211-232","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":15,"title":["Evolution of the inclusion\/exclusion criteria and primary endpoints in pivotal trials of biologics and small oral molecules for the treatment of psoriasis"],"prefix":"10.1080","volume":"13","author":[{"given":"Shao-Hsuan","family":"Hsu","sequence":"first","affiliation":[{"name":"Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan"},{"name":"Department of Dermatology, National Taiwan University Hospital Yun-Lin Branch, Yunlin, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsen-Fang","family":"Tsai","sequence":"additional","affiliation":[{"name":"Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,4,7]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2001.00832.x"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0804595"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1159\/000250839"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1969.01610190092018"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1994.tb02935.x"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14500"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1159\/000232305"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-017-0642-z"},{"issue":"4","key":"cit0009","first-page":"S15","volume":"33","author":"Kavanaugh A","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.127247"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.6.719"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030002"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02430.x"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.080708.082655"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030409"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06688.x"},{"key":"cit0017","first-page":"1177","volume":"159","author":"van de Kerkhof PC","year":"2008","journal-title":"Br J Dermatol"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67566-6"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.09.010"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08315.x"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.04.012"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.04.013"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.53.3.457"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000077913.60364.D2"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60725-4"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60726-6"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13469"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810652"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12177"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10418.x"},{"key":"cit0031","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/j.1468-3083.2012.04705.x","volume":"27","author":"Langley RG","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314258"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.04.011"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.05.013"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13814"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.07.058"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17351"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2017.1329511"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-301668"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.298"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16050"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1512711"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60125-8"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16426"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15666"},{"key":"cit0046","unstructured":"ClinicalTrials.gov. A study of ixekizumab (LY2439821) compared to guselkumab in participants with moderate-to-severe plaque psoriasis (IXORA-R). 2018 [cited 2019 Dec 15]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03573323?term=IXORA-R&draw=2&rank=1"},{"key":"cit0047","unstructured":"ClinicalTrials.gov. Study of ixekizumab (LY2439821) in children 6 to less than 18 years with moderate-to-severe plaque psoriasis (Ixora-peds). 2017 [cited 2019 Dec 15]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03073200?term=IXORA-peds&draw=2&rank=1"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14493"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1503824"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17318"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.08.024"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.11.041"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.11.042"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15750"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31773-8"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31279-5"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18232"},{"key":"cit0058","first-page":"e248","volume":"177","author":"Blauvelt APK","year":"2017","journal-title":"Br J Dermatol"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31713-6"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30952-3"},{"key":"cit0061","unstructured":"ClinicalTrials.gov. A study of the safety and efficacy of risankizumab in adult participants with plaque psoriasis who have had a suboptimal response to secukinumab or ixekizumab (aimm). 2019 [cited 2019 Dec 15]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04102007?term=AIMM&cond=plaque+psoriasis&draw=1&rank=1"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14018"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.03.049"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14164"},{"issue":"310","key":"cit0065","first-page":"e311","volume":"77","author":"Crowley J","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2017.1378343"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1936.01470080123009"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-019-00688-3"}],"container-title":["Expert Review of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17512433.2020.1743175","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T04:37:08Z","timestamp":1722573428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17512433.2020.1743175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,3]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3,3]]}},"alternative-id":["10.1080\/17512433.2020.1743175"],"URL":"https:\/\/doi.org\/10.1080\/17512433.2020.1743175","relation":{},"ISSN":["1751-2433","1751-2441"],"issn-type":[{"value":"1751-2433","type":"print"},{"value":"1751-2441","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-01-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}